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ORIGINAL RESEARCH

Quantitative Ultrasound Assessment of
Duchenne Muscular Dystrophy Using
Edge Detection Analysis
Sisir Koppaka, BS, Irina Shklyar, MD, Seward B. Rutkove, MD, Basil T. Darras, MD,
Brian W. Anthony, PhD, Craig M. Zaidman, MD, Jim S. Wu, MD
Objectives—The purpose of this study was to investigate the ability of quantitative ultrasound (US) using edge detection analysis to assess patients with Duchenne muscular
dystrophy (DMD).
Methods—After Institutional Review Board approval, US examinations with fixed technical parameters were performed unilaterally in 6 muscles (biceps, deltoid, wrist flexors,
quadriceps, medial gastrocnemius, and tibialis anterior) in 19 boys with DMD and 21
age-matched control participants. The muscles of interest were outlined by a tracing
tool, and the upper third of the muscle was used for analysis. Edge detection values for
each muscle were quantified by the Canny edge detection algorithm and then normalized to the number of edge pixels in the muscle region. The edge detection values were
extracted at multiple sensitivity thresholds (0.01–0.99) to determine the optimal threshold for distinguishing DMD from normal. Area under the receiver operating curve values
were generated for each muscle and averaged across the 6 muscles.

Received April 23, 2015, from the Laboratory for
Manufacturing and Productivity (S.K., B.W.A.)
and Medical Electronic Device Realization
Center (S.K., B.W.A.), Massachusetts Institute of
Technology, Cambridge, Massachusetts USA;
Departments of Neurology (I.S., S.B.R.) and
Radiology (J.S.W.), Beth Israel Deaconess
Medical Center, Boston, Massachusetts USA;
Department of Neurology, Boston Children’s
Hospital, Boston, Massachusetts USA (B.T.D.);
and Departments of Neurology and Pediatrics,
Washington University, St Louis Missouri USA
(C.M.Z.). Revision requested August 28, 2015.
Revised manuscript accepted for publication
December 13, 2015.
This study was funded by the National
Institutes of Health grant R01 AR060850-01A1.
Address correspondence to Jim S. Wu, MD,
Department of Radiology, Beth Israel Deaconess
Medical Center, 330 Brookline Ave, Boston, MA
02215 USA.
E-mail: jswu@bidmc.harvard.edu
Abbreviations

DMD, Duchenne muscular dystrophy; US,
ultrasound
doi:10.7863/ultra.15.04065

Results—The average age in the DMD group was 8.8 years (range, 3.0–14.3 years),
and the average age in the control group was 8.7 years (range, 3.4–13.5 years). For edge
detection, a Canny threshold of 0.05 provided the best discrimination between DMD and
normal (area under the curve, 0.96; 95% confidence interval, 0.84–1.00). According to
a Mann-Whitney test, edge detection values were significantly different between DMD
and controls (P < .0001).
Conclusions—Quantitative US imaging using edge detection can distinguish patients
with DMD from healthy controls at low Canny thresholds, at which discrimination of
small structures is best. Edge detection by itself or in combination with other tests can
potentially serve as a useful biomarker of disease progression and effectiveness of therapy
in muscle disorders.
Key Words—Duchenne muscular dystrophy; edge detection; muscle; musculoskeletal
ultrasound; quantitative ultrasound

D

uchenne muscular dystrophy (DMD) is the most common
muscular dystrophy of childhood and affects 1 per 3600
male births.1 The disease is caused by mutations in the dystrophin gene, leading to progressive muscle weakness, which ultimately results in death due to respiratory and cardiac failure.2,3
Accurate, practical, and painless tests to diagnose DMD and measure disease progression are needed to test the effectiveness of new
therapies.4 Current clinical outcome measures such as the 6-minute
walk test and North Star Ambulatory Assessment can be subjective
and limited by the patient’s degree of effort and cannot be accurately
performed in very young or severely affected older patients.5–7
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Quantitative ultrasound (US) is a painless, easy-to-use,
and effective test that is not affected by patient effort.
Recent studies have shown that quantitative US, using
grayscale luminosity, can distinguish diseased from healthy
muscle in several childhood neuromuscular disorders.8–12
In many neuromuscular disorders, including DMD, intramuscular fibrosis and fatty infiltration occur and will increase
the echo intensity of the muscle on grayscale US images.13
The echo intensity of the muscle can be quantified by many
commercially available software programs, which convert
the US image into a distribution of grayscale values.
Patients with DMD will have higher muscle echo intensity
compared to healthy control individuals.
Edge detection is a fundamental technique in the field
of image processing and has been in use for decades, especially for feature detection; however, its use in medicine is
relatively limited.14–16 Edge detection has been used effectively in clinical medicine to assess the size of cardiac
chambers, prostate gland size, and intima-media thickness
in blood vessels from US images.16–20 Abrupt intensity
changes (edges) can indicate the boundaries of these
anatomic structures, determining their areas or volumes
quickly. However, in addition to determining the boundaries of an object to assess for area or volume, quantifying
the number of edges per region of interest (edge density)
can also assess textural variations within the object. It is this
value that we believe is most advantageous when evaluating
US images of diseased muscle. Points where the image
brightness changes abruptly are termed edges, and identifying edges within an image can be used to determine the
boundaries of an object.
There are several algorithms that can be used to perform
edge detection, including Sobel, Prewitt, discrete singular
convolution, and Canny algorithms.14,21,22 We choose the
Canny algorithm for this pilot study because of its simplicity and more common use. These factors would increase
the likelihood that our findings could be reproduced by
researchers without extensive engineering expertise;
however, it would be important in future trials to identify
which edge detection algorithms are best. In the Canny
algorithm, by adjusting the threshold for the detection of
edges, one can assess textural differences between differentsize structures within the image.14 Lower Canny thresholds
are better at distinguishing small structural differences,
whereas higher thresholds can distinguish larger structures.
In skeletal muscle, fibrous tissue is present within the
muscle and between muscles, forming intramuscular and
intermuscular septa, respectively (Figure 1). As the
muscle becomes affected by DMD, fibrosis and fatty
infiltration occur, which lead to increase echogenicity on
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grayscale images.13 This factor makes distinguishing the
echogenic septa within and between muscles harder to
perform as the disease progresses. Alterations in the normal
structural pattern of the muscle could be quantifiable by a
change in the number of edges detected in the US image.
It is our hypothesis that patients with DMD will have
substantially more “edges” in their muscles compared to
healthy boys. The purpose of this pilot study was to investigate the ability of quantitative US, using edge detection
and quantification analysis, to distinguish patients with
DMD from healthy control participants in the hope that it
could serve as a useful measure of disease status and the
effect of therapy.

Materials and Methods
Patient Selection
The Institutional Review Board of Boston Children’s
Hospital approved this prospective study. Informed written
consent and verbal assent were obtained, respectively, from
parents and children. Consecutive boys with DMD were
recruited and enrolled in the study through our neuromuscular disorders clinic and had genetic mutations and a
clinical presentation consistent with DMD. Boys with DMD
were excluded if they were involved in an ongoing clinical
therapeutic trial or if they had another neuromuscular or
other medical condition that substantially affected health.
Consecutive age-matched healthy participants were
recruited by advertisement and via family members and did
not have a history of neuromuscular disease or other disease
that would substantially affect health.
Ultrasound Examinations
All US examinations were performed with the same
portable Terason t3000 system (Teratech, Inc, Burlington,
MA) with a 10-MHz linear transducer within 2 years of the
purchase of the machine. The machine performs system
diagnostics with each boot-up and includes the following: (1) frequency test, which tests system clocks for accuracy (<0.02% variation); (2) noise test, which tests that
maximum system noise is less than 1 least-significant bit;
(3) analog loop-back signal test, which injects simulated
signals into the analog front end to verify signal-channel
integrity and channel matching; and (4) voltage test, which
tests power supply voltages (<0.4% variation). In no cases
did we receive any diagnostic errors during the use of the
system. Transverse US images of 6 muscles (biceps brachii,
deltoid, wrist flexors, quadriceps, tibialis anterior, and
medial gastrocnemius) on the patient’s dominant side
were obtained. Dominance was determined by asking the
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child or parent, and when unknown, the child was given a
ball to throw to assess his dominant side. Ultrasound settings (gain, compression, time-gain compensation, and
depth) were kept constant for all image acquisitions, similar to past studies.8,23,24 Variations in these US parameters
could theoretically change the intensity of the pixels and
change the number of edges detected; thus, these settings
were fixed. Research assistants, trained by a musculoskeletal radiologist (J.S.W.), obtained all US images with the
transducer oriented perpendicular to the long axis of the
muscle of interest. Ultrasound images were obtained with
the participant seated and the knee bent at 90° and the arm
extended at midchest height with the elbow straight and
supported by the examiner or a pillow. The anatomic locations of the US transducer for the various muscle measurements are listed in Table 1.
Ultrasound Image and Data Analysis
Ultrasound images were exported from the Terason software to MATLAB version 7.14 software (The MathWorks,
Natick, MA) as tagged image file format files. The muscle

of interest was outlined with a polygonal region-tracing tool
by a single musculoskeletal radiologist (J.S.W.). The area
of the muscle, measured as the number of pixels, was calculated from the traced image. The analysis was made on
a pixel basis, since we believe that this approach would
best correlate with the textural changes that occur in the
muscle with DMD disease. The pixel pitch was held constant by choosing the same physical parameters for image
length and width during acquisition. Only the upper third
of the traced muscle area was used for analysis (Figure 2),
as described by Jansen et al,10 since there is attenuation
of sound waves in the deeper tissue, making analysis of
deeper structures in the image less effective. Edge detection
values were quantified by using the Canny edge detection
algorithm14 in MATLAB. The Canny algorithm detects
edges in the image and produces a binary map of the edges.
The number of edges, measured in edge pixels highlighted
by the Canny algorithm, present in each muscle region
(upper third) was then divided by the number of pixels in
that same area of muscle to arrive at the edge detection
value (unitless value). This value gives a normalized

Figure 1. Edge detection analysis of a grayscale US image. A, Grayscale US image of the quadriceps muscle in a 7-year-old control participant.
B, Binary image using edge detection Canny analysis of A. Note that the echogenic superficial fascia (arrowheads), muscle septa (thin arrows), and
femoral cortex (thick arrow) on the grayscale image appear as bright curves (edges) on the binary image. The above edges are depicted at a sensitivity threshold of 0.40.
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measure of the number of edges in the muscle region being
evaluated.
The edge detection values for all 6 muscle groups were
extracted at multiple thresholds of sensitivity by using the
Canny algorithm to determine the optimal threshold for
distinguishing DMD from normal. The detector takes a
Table 1. Anatomic Locations of US Measurements
Muscle

Location

Deltoid

One-fifth distance from acromion to
lateral epicondyle
Arm supine, two-thirds distance from
acromion to antecubital fossa
Arm supine, one-third distance from medial
epicondyle to base of thumb
Two-thirds distance from inguinal crease to
superior aspect of patella, seated knee bent
One-fourth distance from fibula head to
lateral malleolus midpoint, seated,
ankle neutral
One-third distance from inferior aspect of
popliteal fossa to medial malleolus, seated,
ankle neutral

Biceps brachii
Wrist/finger flexors
Quadriceps
Tibialis anterior

Medial
Gastrocnemius

threshold parameter for sensitivity, which can vary from 0.01
to 0.99. We generated a Canny binary map for all 99
thresholds between 0.01 and 0.99 at 0.01 intervals (Figure 3).
This process allowed us to capture not only the number of
edges detected per muscle area but also the behavior of the
image as a function of edge thresholds. In addition, we
attempted to maximize the signal-to-noise ratio for each
Canny threshold by removing single isolated edge pixels
that did not have connectivity to other edge pixels. This
process would reduce the noise that could affect image
analysis. This technique was performed for both the DMD
and control participants.
Statistical Analysis
Area under the receiver operating curve values for edge
detection thresholds were generated for each muscle and
the average of all 6 muscles using MedCalc version 14.8.1
software (MedCalc, Ostend, Belgium). The Mann-Whitney
test was used to determine differences in edge detection
values between patients with DMD and control participants, with P ≤ .05 considered significant.

Figure 2. Muscle tracing and region of interest used in the analysis. A, Grayscale US image of the quadriceps muscles in a 6-year-old control
participant. B, The traced muscle area (between white curves) excludes the subcutaneous tissue/skin, bone, and deeper tissues. The dotted line
and double arrows denote the upper third of the muscle area used for analysis.
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Results
Patient Demographics
The average age in the DMD group was 8.8 years (range,
3.0–14.3 years), and the average age in the control group
was 8.7 years (range, 3.4-13.5 years). Of the 19 boys with
DMD, 9 were receiving corticosteroid therapy, and 11
were in the 4- to 10-year age group. Of the 21 controls,
12 were in the 4- to 10-year age group.
Ultrasound Image and Data Analysis
For the edge detection and quantification analysis, among
the 99 Canny sensitivity thresholds tested (0.01–0.99),
a threshold of 0.05 was the optimal threshold for distinguishing DMD from normal (Figure 4 and Table 2).
Thus, this threshold was used for all subsequent analyses. Using the average of the 6 muscles, edge detection
was excellent at distinguishing DMD from normal. For
the individual muscles, edge detection was best at distinguishing DMD from normal in the gastrocnemius and
poorest in the anterior tibialis, as listed in Table 3 and
shown in Figure 5.

For each of the 6 muscles, there were more edges
detected in the DMD group compared to the control group.
This finding was also true when all 6 muscle groups were
averaged together: DMD had a median edge detection
value of 0.231 (range, 0.208–0.238), whereas the control
group had a median edge detection value of 0.210 (range,
0.197–0.221; P < .0001).

Discussion
There is a high need for accurate biomarkers capable of
measuring disease progression and drug efficacy in muscle
disorders, such as DMD, over time.25 In this prospective
study, our results show that quantitative US using edge
detection and edge quantification analysis was capable of
distinguishing between boys with DMD and controls with
high accuracy. We found, as hypothesized, that the muscle of
patients with DMD had more edges on the US images compared to controls. With disease progression, the muscles in
patients with DMD become infiltrated with echogenic
fibrous tissue and fat, which obscure the similarly echogenic
intramuscular and intermuscular septa (Figure 6).13

Figure 3. Edge detection and quantification images at different Canny sensitivity thresholds. A and F, Ultrasound images of the quadriceps muscles in a 6-year-old patient with DMD (A) and a 6-year-old control participant (F). Note the increased echo intensity of the muscle in the patient with
DMD and poor visualization of the intermuscular fascial bands and bone. The corresponding edge detection images detected at Canny sensitivity
thresholds of 0.05 (B and G), 0.10 (C and H), 0.20 (D and I), and 0.40 (E and J) are shown. More edges are detected at the lower thresholds than
the higher thresholds in the patient with DMD compared to the control participant.

J Ultrasound Med 2016; 35:1889–1897
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Figure 4. Receiver operating characteristic curves for the various Canny edge detection (ED) thresholds. Edge detection of 0.05 was the optimal
threshold for distinguishing DMD from normal.

Moreover, by using edge detection and quantification
analysis, we were able to distinguish patients with DMD
from the healthy control participants, similar to other quantitative US studies, which have relied primarily on variations
in muscle echo intensity.10,23,24 In these echo intensity
studies, a region-of-interest box was placed inside the
muscle, or tracing of the muscle of interest was performed,
and grayscale echo intensity values were generated.10,23,24
In general, diseased muscle has higher echo intensity than
normal muscle because of deposition of fibrous tissue and
fat, and this increased intensity has been shown to occur
in a variety of diseases, including DMD.8,10,26 It is unclear
whether the increase in edges seen in this study and
increased echo intensity values seen in past studies of patients
with DMD indicated corresponding structural changes in
the muscle.
Edge detection has the ability to selectively evaluate
different components of muscle, which is not entirely possible with echo intensity analysis. In edge detection, lower
Canny sensitivity thresholds correspond to edges with
smaller dimensions (length) and are more representative
of smaller components of muscle, such as the muscle
fascicles and intramuscular septa, whereas higher sensitivity thresholds correspond to longer edge dimensions
and larger structures, such as the intermuscular fascia. By
adjusting sensitivity thresholds, one can assess differences
in the various structural components of the muscle. In this
study, edge detection was best at the lower Canny thresholds for distinguishing DMD from normal, suggesting
that the muscle changes can be attributed to the smaller
edges and therefore the small components of muscle.
Interestingly, it is more difficult to perceive visual differences in the number of edges between DMD and controls
1894

at the lower Canny thresholds than at the higher levels.
However, when edge detection analysis is performed, the
lower Canny thresholds reveal more substantial differences
between the groups.
Edge detection analysis was able to distinguish
between DMD and controls for each of the 6 muscles and
with the average of the 6 muscles. Moreover, edge detection
performed best when evaluating the gastrocnemius.
This result is supported by past imaging studies using
computed tomography and magnetic resonance imaging,
which have shown that muscle atrophy with fatty infiltration is most pronounced in the posterior as opposed to the
anterior calf muscles.27–29 In fact, the anterior compartment
muscles are often normal on imaging even with longstanding disease.28,29 Clinically, calf pseudohypertrophy is
a characteristic finding in DMD, in which, despite circumferential enlargement of the calf from fat deposition, muscle weakness is present.25

Table 2. Area Under the Curve Values at Different Canny Edge
Detection Thresholds for the 6-Muscle Average
Threshold

AUC

95% CI

0.05
0.10
0.15
0.20
0.40
0.60
0.80
0.95

0.95
0.90
0.87
0.82
0.55
0.60
0.56
0.57

0.83–0.99
0.77–0.97
0.73–0.96
0.67–0.92
0.39–0.71
0.44–0.75
0.39–0.71
0.41–0.72

AUC indicates area under the curve; and CI, confidence interval.
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A few limitations deserve mention. First, this work was
a cross-sectional pilot study, and the sample size was relatively small, with roughly 20 participants in each group.
Future longitudinal studies with larger numbers of participants will assess whether edge detection has the ability
to monitor disease progression and efficacy of therapies.

Another limitation was the inability to change US
parameters during image acquisition. Altering the depth,
gain, or focus could affect the appearance of the final
image and intensity of pixels within the image and change
the number of edges detected. However, the settings
were identical for all muscles and participants, and this

Table 3. Quantitative US Evaluation of DMD Using Edge Detection and Quantification Analysis
ED (±SD)
Muscle
Biceps
Deltoid
Wrist flexors
Quadriceps
Gastrocnemius
Tibialis anterior
All 6 muscles

Control
0.213 (0.010)
0.207 (0.010)
0.204 (0.011)
0.215 (0.011)
0.207 (0.008)
0.212 (0.016)
0.210 (0.006)

DMD
0.234 (0.010)
0.223 (0.014)
0.223 (0.010)
0.231 (0.014)
0.234 (0.015)
0.226 (0.013)
0.231 (0.008)

AUC

95% CI

P

0.91
0.86
0.92
0.92
0.97
0.80
0.96

0.78–0.98
0.71–0.95
0.78–0.98
0.79–0.98
0.86–1.00
0.64–0.91
0.84–1.00

<.0001
<.0001
<.0001
<.0001
<.0001
.0001
<.0001

AUC indicates area under curve; CI, confidence interval; and ED, edge detection.

Figure 5. Receiver operating characteristic curves for edge detection (ED) analysis in 6 muscles: biceps, deltoid, wrist flexors, quadriceps (quad),
gastrocnemius (gastroc), and tibialis anterior (TA).

J Ultrasound Med 2016; 35:1889–1897
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technique has been shown to be effective for several neuromuscular disorders and research groups.8,10,24,30,31 Using
raw frequency or backscatter data could potentially correct
for this issue.9,26 Last, tissue motion, either by the patient or
examiner, during acquisition of the US images could impact
the reliability of the technique, affecting the resolution and
number of edges in the images. However, the US imaging
techniques used in this study have been shown in a prior
study of boys with DMD to have high inter-rater reliability
(intraclass correlation coefficient, ≥0.85), in research assistants with only a 20-minute training session.23 Moreover,
great care was taken to acquire images without motion artifacts, and muscle tremors by the patient were very uncommon. Furthermore, the techniques used were identical
between controls and patients with DMD; thus, potential
issues related to tissue motion would likely be equal in both
groups. In future studies, we plan to include a force stabilization attachment to our US transducers.

In conclusion, quantitative US using edge detection
analysis can distinguish patients with DMD from healthy
control participants at low sensitivity thresholds, at which
discrimination of small structures is best. Although edge
detection is a somewhat rudimentary method for characterizing texture, based on our results, this technique
appears to work well for distinguishing muscle disease in
DMD from normal. Future studies with more patients
evaluated over several time points are needed to determine whether edge detection by itself or in combination
with other tests can improve the assessment of disease
progression and drug efficacy in muscle disorders, including DMD.

Figure 6. Ultrasound images of 6 muscles in a patient with DMD and a control participant. The 9-year-old patient with DMD (top row) has
increased muscle echo intensity and obscuration of the intermuscular/intramuscular septa and bone compared to the 9-year-old control participant (bottom row).
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